Avandia

Type: Product
Name: Avandia
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Should Dr. Oz be Silenced?

Mehmet Oz – World Economic Forum Annual Meeting 2012 – Source: WikimediaMedical Student Launches Campaign Against Dr. Ozby Alliance for Natural HealthAs his popularity with Americans grows—and with it a new openness to integrative medicine—mainstream ... [Published Health Impact News - Jul 29 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Safety profile of blockbuster blood thinner comes under question

The BMJ probe also suggests that there may be safety benefits to monitoring Pradaxa's anticoagulant effect on individual patients -- a practice deemed unnecessary by the Food and Drug Administration when it approved the medication's marketing four years ... [Published Los Angeles Times - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

People with more brown fat better able to control blood sugar

Researchers have known that brown fat has an influence on metabolism but a recent study has shown that in addition to burning calories, brown fat can also help with . Researchers from the University of Texas Medical Branch (UTMB) reviewed the effects ... [Published Diabetes.co.uk - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

What Do We Want Out of Our Diabetes Treatments?

We want our diabetes treatments to be effective, but we also want them to be safe, and it is up to the FDA to decide if the benefits of a given medication outweigh the risks. Consider insulin: if misused, it can kill you, but its benefits – it keeps all ... [Published diaTribe - Jul 24 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Database provides fresh evidence of effect of diabetes drugs on Alzheimer's

While clinical trials remain the gold standard for proving safety and efficacy, the scale, real-world mix of patients and relatively low costs associated with database-powered studies make them a useful option for researchers. This week a German team ... [Published Fierce Biotech IT - Jul 18 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Attorney Bryan Schefman Wins in US Court of Appeals July 16, 2014:...

Attorney Bryan Schefman argued successfully for the right of medical providers to seek charges and double damages under the Medicare Secondary Payor (“MSP”) act where a no-fault insurer has denied PIP benefits to a Medicare eligible insured. The Court ... [Published PRWeb - Jul 18 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Settlement Over Deceptive Implant Marketing

Johnson & Johnson (“J&J”) has reached a four million settlement with the state of Oregon to resolve allegations that J&J improperly marketed its DePuy ASR metal-on-metal hip implants.  J&J has recalled 93,000 ASR hip implants, which had a 12% failure ... [Published JD Supra - Jul 10 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

Baron and Budd Now Accepting Cases Involving Defibrillator...

St. Jude Medical’s Riata, Riata ST and Durata Models Among Those That Can Cause Major Health Issues The national law firm of Baron and Budd is now accepting cases involving the malfunction of certain heart defibrillators implanted in patients. These faulty ... [Published PRWeb - Jul 07 2014]
First reported Jun 27 2014 - Updated Jun 27 2014 - 1 reports

GlaxoSmithKline to Pay $105 Million to Settle Claims Over the...

GlaxoSmithKline agreed to pay $105 million to settle claims by California, New York, and more than 40 other states that it illegally promoted three of its antidepressants and asthma drugs. Flood Law Group is investigating potential Paxil claims in light ... [Published PRWeb - Jun 27 2014]
First reported Jun 16 2014 - Updated Jun 16 2014 - 1 reports

Baron and Budd reaches $177m settlement for seven states against GlaxoSmithKline

The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of the states of Kentucky, Maryland, Mississippi, New Mexico, South Carolina, Utah and West Virginia regarding the deceptive advertising of the ... [Published Pharmaceutical Business Review - Jun 16 2014]
First reported Jun 13 2014 - Updated Jun 13 2014 - 6 reports

Baron and Budd Announces $177 Million Settlement for Seven States Against Avandia Manufacturer GlaxoSmithKline

DALLAS, Jun 13, 2014 (BUSINESS WIRE) -- The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of the states of Kentucky, Maryland, Mississippi, New Mexico, South Carolina, Utah and West Virginia regarding ... [Published PharmaGossip - Jun 13 2014]
First reported Jun 03 2014 - Updated Jun 03 2014 - 1 reports

Permitted Gamesmanship v. Prohibited Conduct

br />!--[if gte mso 10]> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; ... [Published Drug and Device Law - Jun 03 2014]
Entities: Avandia, Fraud, State Court

Quotes

In an apparent bid to position Pradaxa as an improvement on a long-used medication, Boehringer-Ingelheim "withheld from the [FDA's] regulators important analyses regarding how to use the drug as safely and effectively as possible" wrote BMJ's investigations editor, Deborah Cohen
...Diseases concluded that long-term Actos use cuts the risk of dementia, but others have questioned the real-world significance of the results. "It's actually almost surprising to me that the lowering of relative risk was so weak" Boston University professor Ben Wolozin told Bloomberg...
...founded, 4D Biomedical, with the emphasis being on encouraging collaboration between the National Health Service (NHS), universities and industry. "It's about making sure that Britain is unlocking and using all of our assets through the NHS, through medical research" Freeman told BBC Radio Norfolk this week...
The FDA said it "expects ID Biomedical and GSK to undertake a comprehensive and global assessment of all of its manufacturing operations to ensure that all products conform to FDA requirements"

More Content

All (42) | News (28) | Reports (0) | Blogs (14) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Should Dr. Oz be Silenced? [Published Health Impact News - Jul 29 2014]
People with more brown fat better able to contr... [Published Diabetes.co.uk - Jul 24 2014]
What Do We Want Out of Our Diabetes Treatments? [Published diaTribe - Jul 24 2014]
Safety profile of blockbuster blood thinner com... [Published Los Angeles Times - Jul 24 2014]
5 More Possible Partners For MannKind's Afrezza... [Published Seeking Alpha - Jul 21 2014]
Database provides fresh evidence of effect of d... [Published Fierce Biotech IT - Jul 18 2014]
Attorney Bryan Schefman Wins in US Court of App... [Published PRWeb - Jul 18 2014]
U.K. gov names ex-biotech VC as life sci chief,... [Published FierceBiotech - Jul 18 2014]
FDA Once Again Reaches Conclusions At Odds With... [Published Forbes.com - Jul 14 2014]
Settlement Over Deceptive Implant Marketing [Published JD Supra - Jul 10 2014]
Status Conference Regarding Risperdal Litigatio... [Published PRWeb - Jul 08 2014]
Baron and Budd Now Accepting Cases Involving De... [Published PRWeb - Jul 07 2014]
The Lab for These FDA Scientists Is a Computer ... [Published U.S. Food and Drug Administration - Jul 01 2014]
GlaxoSmithKline to Pay $105 Million to Settle C... [Published PRWeb - Jun 27 2014]
Study Reveals How Omega-3′s Provide Protection ... [Published Daily Times Nigeria - Jun 27 2014]
FDA orders GlaxoSmithKline to review manufactur... [Published Guardian.co.uk - Jun 24 2014]
New Order Issued, Paving the Way for Federal Li... [Published PRWeb - Jun 23 2014]
More Than 1,700 GranuFlo Cases Filed in Federal... [Published PRWeb - Jun 21 2014]
Status Conference on GranuFlo Lawsuits Held, Ba... [Published PRWeb - Jun 18 2014]
Baron and Budd reaches $177m settlement for sev... [Published Pharmaceutical Business Review - Jun 16 2014]
Baron and Budd Announces $177 Million Settlemen... [Published PharmaGossip - Jun 13 2014]
Baron and Budd Announces $177 Million Settlemen... [Published EON Business - Jun 13 2014]
Baron and Budd Announces $177 Million Settlemen... [Published Business Wire Photo/Multimedia News - Jun 13 2014]
Baron and Budd Announces $177 Million Settlemen... [Published Business Wire Professional Services News - Jun 13 2014]
Baron and Budd Announces $177 Million Settlemen... [Published Business Wire Health News - Jun 13 2014]
Baron and Budd Announces $177 Million Settlemen... [Published Business Wire News with Multimedia - Jun 13 2014]
GSK To Pay $105 Million To Settle Advair, Paxil... [Published The Consumerist - Jun 04 2014]
Permitted Gamesmanship v. Prohibited Conduct [Published Drug and Device Law - Jun 03 2014]
Who Should and Who Shouldn’t Take Daily Aspirin [Published TIME.com - May 08 2014]
Russell Budd of Baron and Budd Appointed to Pla... [Published PRWeb - May 08 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Baron and Budd Announces $177 Million Settlemen... [Published PharmaGossip - Jun 13 2014]
DALLAS, Jun 13, 2014 (BUSINESS WIRE) -- The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of the states of Kentucky, Maryland, Mississippi, New Mexico, South Carolina, Utah and West Virginia regarding ...
Baron and Budd Announces $177 Million Settlemen... [Published EON Business - Jun 13 2014]
DALLAS--(EON: Enhanced Online News)--The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of seven states. ...
Baron and Budd Announces $177 Million Settlemen... [Published Business Wire Photo/Multimedia News - Jun 13 2014]
DALLAS--(BUSINESS WIRE)--The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of seven states. ...
Baron and Budd Announces $177 Million Settlemen... [Published Business Wire Professional Services News - Jun 13 2014]
DALLAS--(BUSINESS WIRE)--The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of seven states. ...
Baron and Budd Announces $177 Million Settlemen... [Published Business Wire Health News - Jun 13 2014]
DALLAS--(BUSINESS WIRE)--The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of seven states. ...
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.